Norden Group LLC Sells 1,302 Shares of U.S. Physical Therapy, Inc. (NYSE:USPH)

Norden Group LLC lowered its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 28.8% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The firm owned 3,226 shares of the company’s stock after selling 1,302 shares during the quarter. Norden Group LLC’s holdings in U.S. Physical Therapy were worth $298,000 at the end of the most recent reporting period.

Several other large investors have also recently bought and sold shares of USPH. Vanguard Group Inc. boosted its stake in U.S. Physical Therapy by 1.0% in the 1st quarter. Vanguard Group Inc. now owns 1,072,602 shares of the company’s stock worth $121,065,000 after purchasing an additional 10,175 shares during the period. Southernsun Asset Management LLC raised its holdings in U.S. Physical Therapy by 5.9% during the fourth quarter. Southernsun Asset Management LLC now owns 479,214 shares of the company’s stock worth $44,634,000 after acquiring an additional 26,758 shares in the last quarter. Schroder Investment Management Group boosted its holdings in shares of U.S. Physical Therapy by 11.0% in the 4th quarter. Schroder Investment Management Group now owns 427,217 shares of the company’s stock valued at $39,791,000 after buying an additional 42,281 shares during the last quarter. Dimensional Fund Advisors LP lifted its stake in U.S. Physical Therapy by 3.7% in the fourth quarter. Dimensional Fund Advisors LP now owns 400,183 shares of the company’s stock valued at $37,274,000 after acquiring an additional 14,344 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its position in shares of U.S. Physical Therapy by 3.4% in the 2nd quarter. Bank of New York Mellon Corp now owns 157,052 shares of the company’s stock valued at $14,515,000 after acquiring an additional 5,111 shares during the period.

Analyst Ratings Changes

USPH has been the topic of several research analyst reports. Barrington Research dropped their price objective on U.S. Physical Therapy from $122.00 to $108.00 and set an “outperform” rating on the stock in a research note on Thursday, August 15th. StockNews.com upgraded U.S. Physical Therapy from a “sell” rating to a “hold” rating in a research note on Wednesday, August 21st. One investment analyst has rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $112.50.

U.S. Physical Therapy Trading Down 1.0 %

Shares of NYSE:USPH opened at $83.71 on Tuesday. The business has a 50 day moving average of $90.13 and a 200-day moving average of $98.22. The stock has a market cap of $1.26 billion, a PE ratio of 68.06, a P/E/G ratio of 4.14 and a beta of 1.39. U.S. Physical Therapy, Inc. has a 12-month low of $78.08 and a 12-month high of $113.63. The company has a quick ratio of 1.88, a current ratio of 1.88 and a debt-to-equity ratio of 0.28.

U.S. Physical Therapy (NYSE:USPH) last announced its earnings results on Tuesday, August 13th. The company reported $0.73 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.82 by ($0.09). The business had revenue of $167.19 million for the quarter, compared to analyst estimates of $163.34 million. U.S. Physical Therapy had a return on equity of 8.18% and a net margin of 4.06%. The business’s revenue for the quarter was up 10.4% on a year-over-year basis. During the same quarter in the previous year, the company earned $0.76 EPS. As a group, equities research analysts forecast that U.S. Physical Therapy, Inc. will post 2.51 earnings per share for the current year.

U.S. Physical Therapy Announces Dividend

The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 13th. Shareholders of record on Friday, August 23rd will be given a dividend of $0.44 per share. The ex-dividend date of this dividend is Friday, August 23rd. This represents a $1.76 annualized dividend and a yield of 2.10%. U.S. Physical Therapy’s dividend payout ratio is currently 143.09%.

Insiders Place Their Bets

In other U.S. Physical Therapy news, Director Kathleen A. Gilmartin acquired 2,000 shares of U.S. Physical Therapy stock in a transaction that occurred on Tuesday, September 3rd. The shares were acquired at an average cost of $86.09 per share, with a total value of $172,180.00. Following the completion of the purchase, the director now directly owns 18,904 shares of the company’s stock, valued at approximately $1,627,445.36. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. In related news, COO Graham D. Reeve sold 1,724 shares of the business’s stock in a transaction on Wednesday, August 21st. The shares were sold at an average price of $82.50, for a total value of $142,230.00. Following the sale, the chief operating officer now owns 7,038 shares of the company’s stock, valued at $580,635. The sale was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Kathleen A. Gilmartin acquired 2,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 3rd. The stock was bought at an average price of $86.09 per share, with a total value of $172,180.00. Following the completion of the acquisition, the director now directly owns 18,904 shares of the company’s stock, valued at $1,627,445.36. The disclosure for this purchase can be found here. Corporate insiders own 1.70% of the company’s stock.

U.S. Physical Therapy Profile

U.S. Physical Therapy, Inc operates outpatient physical therapy clinics. The company operates through Physical Therapy Operations and Industrial Injury Prevention Services segments. The company provides pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries.